Clinitech Laboratory Limited
ListedSMEHealthcare · BSE
Clinitech Laboratory Limited, established in 1990, runs 8 diagnostic centers across Thane and Navi Mumbai, offering a wide range of healthcare and diagnostic tests. The company conducts over 3 lakh tests annually in its NABL-accredited labs (National Accreditation Board for Testing and Calibration Laboratories), equipped with advanced technology and high-end equipment. Its Airoli, Navi Mumbai facility holds an ISO 15189:2012 accreditation certificate for quality testing services. As of December 31, 2023, Clinitech has a team of 74 employees dedicated to delivering accurate and reliable healthcare services.
Price Band
₹96
Issue Size
₹5.78 Cr
Lot Size
1200 shares
GMP
₹65
+67.7%
Est. Listing
₹161
at current GMP
Subscribed
34.43x
overall
Open
25 Jul 2024
Close
29 Jul 2024
Allotment
30 Jul 2024
Refund
31 Jul 2024
Demat Credit
1 Aug 2024
Listing
1 Aug 2024
Last updated 12 days ago
Live Grey Market Premium
Clinitech Laboratory Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹65+67.7%
Issue Price (Upper)
₹96
Band: ₹96
Estimated Listing Price
₹161
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,15,200
Estimated Profit / Lot
₹78,000
1200 × ₹65
Clinitech Laboratory Limited GMP Historical Trend
GMP History
Grey Market Premium trend
+₹65
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹65 | 67.7% | ₹161 |
| 30 Oct 2026 | +₹65 | 67.7% | ₹161 |
| 29 Oct 2026 | +₹59 | 60.9% | ₹155 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Clinitech Laboratory Limited Public Issue & Market Profile
Clinitech Laboratory Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹5.78 Crores. The shares are offered at a price band of ₹96 to ₹96 per equity share on BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2024-07-29, the basis of allotment is scheduled to be finalized on 2024-07-30. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Clinitech Laboratory Limited IPO GMP today?
The latest grey market premium for Clinitech Laboratory Limited IPO is ₹65, which indicates an expected listing price of ₹161.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.